Odonate Therapeutics, Inc. Operating Cash Flow
Odonate Therapeutics, Inc. reported Operating Cash Flow of -$63.04 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-11-10
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$15.10M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$23.03M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$24.91M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$31.50M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$113.13M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$96.64M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$67.09M.
- Odonate Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$25.86M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$38.13M derived: sum of 2 quarters · filed 2021-11-10 | -$63.04M 10-Q · filed 2021-11-10 | -$94.54M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | -$23.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$47.94M 10-Q · filed 2021-07-27 | -$79.44M derived: sum of 3 quarters · filed 2021-07-27 | -$104.59M derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | -$24.91M 10-Q · filed 2021-05-14 | -$56.41M derived: sum of 2 quarters · filed 2021-05-14 | -$81.56M derived: sum of 3 quarters · filed 2021-11-10 | -$110.19M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | -$31.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$56.65M derived: sum of 2 quarters · filed 2021-11-10 | -$85.28M derived: sum of 3 quarters · filed 2021-11-10 | -$113.13M 10-K · filed 2021-02-23 |
| 2020-09-30 | -$25.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$53.78M derived: sum of 2 quarters · filed 2021-11-10 | -$81.63M 10-Q · filed 2021-11-10 | -$106.15M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$28.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$56.48M 10-Q · filed 2021-07-27 | -$81.00M derived: sum of 3 quarters · filed 2021-07-27 | -$102.78M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-03-31 | -$27.84M 10-Q · filed 2021-05-14 | -$52.37M derived: sum of 2 quarters · filed 2021-05-14 | -$74.15M derived: sum of 3 quarters · filed 2021-05-14 | -$97.38M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$24.52M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$46.31M derived: sum of 2 quarters · filed 2021-02-23 | -$69.53M derived: sum of 3 quarters · filed 2021-02-23 | -$96.64M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$21.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$45.01M derived: sum of 2 quarters · filed 2020-10-28 | -$72.12M 10-Q · filed 2020-10-28 | -$93.88M derived: sum of 4 quarters · filed 2020-10-28 |
| 2019-06-30 | -$23.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$50.33M 10-Q · filed 2020-07-30 | -$72.10M derived: sum of 3 quarters · filed 2020-07-30 | -$88.34M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | -$27.11M 10-Q · filed 2020-04-28 | -$48.88M derived: sum of 2 quarters · filed 2020-04-28 | -$65.12M derived: sum of 3 quarters · filed 2020-04-28 | -$81.75M derived: sum of 4 quarters · filed 2020-04-28 |
| 2018-12-31 | -$21.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$38.01M derived: sum of 2 quarters · filed 2020-02-20 | -$54.64M derived: sum of 3 quarters · filed 2020-02-20 | -$67.09M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$16.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$32.87M derived: sum of 2 quarters · filed 2019-11-06 | -$45.33M 10-Q · filed 2019-11-06 | -$59.40M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | -$16.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$29.09M 10-Q · filed 2019-07-24 | -$43.16M derived: sum of 3 quarters · filed 2019-07-24 | -$50.83M derived: sum of 4 quarters · filed 2019-07-24 |
| 2018-03-31 | -$12.45M 10-Q · filed 2019-04-25 | -$26.53M derived: sum of 2 quarters · filed 2019-04-25 | -$34.20M derived: sum of 3 quarters · filed 2019-04-25 | |
| 2017-12-31 | -$14.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$21.75M derived: sum of 2 quarters · filed 2019-02-22 | -$25.86M 10-K · filed 2019-02-22 | |
| 2017-09-30 | -$7.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$11.78M 10-Q · filed 2018-10-23 | ||
| 2017-06-30 | -$4.11M 10-Q · filed 2018-07-30 |